The convergence of AI and pharmaceuticals holds immense promise for revolutionizing drug discovery, clinical trials, and healthcare delivery. However, ensuring regulatory compliance is paramount to realizing this potential. This presentation offers a comprehensive overview of AI in pharma and the regulatory roadmaps guiding its implementation. Through interactive discussions and expert insights, attendees will explore the complexities of regulatory compliance in AI-driven pharmaceutical practices and discover practical strategies for overcoming regulatory barriers while fostering innovation and patient-centric care.
Learning Objectives:
1. Familiarize yourself with the transformative impact of AI on various aspects of the pharmaceutical industry, including drug discovery, development, and regulatory affairs.
2. Identify the regulatory challenges and considerations associated with integrating AI technologies into pharmaceutical workflows, including data integrity, validation, and safety.
3. Gain an understanding of the regulatory frameworks governing AI in pharmaceuticals, including FDA guidelines, international standards, and emerging regulatory trends.
4. Develop actionable strategies for navigating regulatory roadmaps effectively, ensuring compliance, and driving ethical, responsible AI adoption in the pharmaceutical sector.
